SCHEMBL289276

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL730014	0.75	PSMB5 (0.34)	PSMB5PSMB8
	SCHEMBL289277	0.75	ACHE (0.39)	PSMB5PSMB8
	SCHEMBL16533399	0.75	PSMB5 (0.34)	PSMB5PSMB8
	SCHEMBL30395048	0.75	ACHE (0.39)	PSMB5PSMB8
	SCHEMBL2096680	0.75	—	—
	SCHEMBL2094327	0.75	LOXL2 (0.33)	—
	SCHEMBL2091325	0.75	CYP1A2 (0.42)	PSMB5PSMB8
	SCHEMBL2089807	0.75	PSMB5 (0.42)	PSMB5PSMB8
	SCHEMBL28990308	0.73	MEN1 (0.37)	PSMB5PSMB8GABRPGABRDGABRA1
	SCHEMBL22645752	0.71	CA2 (0.33)	PSMB5PSMB8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.